Kiran Mazumdar Shaw

May 27, 2015 at 08:44 | Source: PTI
SBI chief Arundhati Bhattacharya, ICICI bank head Chanda Kochhar, Biocon founder Kiran Mazumdar-Shaw and HT Media chairperson Shobhana Bhartia are among the world's 100 most powerful women, according to the Forbes' annual list which is topped by German chancellor Angela Merkel.
Apr 30, 2015 at 12:10 | Source: CNBC-TV18
Biocon's Kiran Mazumdar Shaw said the company deliberately took a hit on its topline in order to rationalize products. Biocon is focusing towards being a specialized products player.
Apr 30, 2015 at 09:06 | Source: Moneycontrol.com
Biocon's fourth quarter profit after tax climbed 78 percent year-on-year to Rs 201 crore led by exceptional gains of Rs 105.06 crore (on account of sale of shares of Syngene).
Apr 23, 2015 at 09:20 | Source: CNBC-TV18
Biocon plans to list its research arm Syngene and on Wednesday filed prospectus with the market regulator Sebi. It aims to raise around Rs 600 crore.
Apr 22, 2015 at 18:09 | Source: CNBC-TV18
Biocon will be offloading at least 10 percent of Syngene equity as it needs funds to support some of its R&D programmes.
Apr 10, 2015 at 11:11 | Source: Moneycontrol.com
Shares of Biocon gained 3 percent intraday Friday on getting approval from the Mexican health authority for its insulin glargine.
Apr 09, 2015 at 21:37 | Source: PTI
The company's insulin Glargine has been approved by Cofepris, the Mexican health authority, through its Mexican partner PiSA Farmaceutica (PiSA), Biocon said in a statement.
Apr 01, 2015 at 13:41 | Source: CNBC-TV18
Kiran Mazumdar Shaw, Chairperson and MD, Biocon also said that Syngene has good growth prospects and sound business plan and has a baseline valuation of Rs 3,800 crore.
Mar 31, 2015 at 16:19 | Source: CNBC-TV18
Take a look at what has made Kiran Mazumdar-Shaw of Biocon a true Indian business icon.
Mar 26, 2015 at 10:44 | Source: CNBC-TV18
Rubbishing concerns that the increasing FDA scrutiny of Indian pharma companieswas a case of "irrational clampdown", Biocon CMD Kiran Mazumdar-Shaw told CNBC-TV18 that the US regulator is mandating more stringent norms for companies across the world.
Messages on Kiran Mazumdar Shaw »

stocktin

Platinum Member

64 Followers

Biocon  

which involves big bucks like the 2g,3g, coal etc.In the similar context industrialists like KMS are flower pots they r the face of Indian industry after all you cant showcase an ex custom house clearing agent like Gautam Adani to the world as the face of Indian Industry for that you need Kiran Mazumdar

6.31 PM Jun 9th 2014

Web Messenger

Platinum Member

293815 Followers

News Now  

Source:VC Circle - The company expects its small molecule API and ANDA business to be lead revenue generator followed by research services, biosimilars and branded formulations. Biocon Ltd is India's largest biotechnology company founded by Kiran Mazumdar-Shaw in ...

2.34 PM May 7th 2014

sanecounsel

Platinum Member

100 Followers

Biocon  

BANGALORE: Kiran Mazumdar-Shaw on Friday for the very first time used the words `succession planning`, after having built Biocon into a Rs 3,000-crore global biopharmaceutical enterprise and making it the poster child of India`s biotech prowess in a span of over three decades. The board of Biocon

11.32 AM Apr 27th 2014

stocktin

Platinum Member

64 Followers

Biocon  

ramanujam11 : Great post & the comparision with Apple .however , I am a little queasy about your first point regarding the ipo ,statin company & the hype.Who benefited from the hype created at the time of ipo?? And if this is true then everything that Biocon and Kiran Mazumdar Shaw stand for can

11.29 AM Mar 15th 2014

Web Messenger

Platinum Member

293815 Followers

News Now  

Source:The Hindu BusinessLine - Indian Institute of Management-Bangalore (IIM-B) has appointed Kiran Mazumdar-Shaw as the Chairperson of its board of governors. At the meeting of the board of governors on February 11, the Chairperson, Mukesh D. Ambani, expressed his decision to step down, IIM

4.35 PM Feb 19th 2014

srikanth031
086

Gold Member

162 Followers

Biocon  

Kiran Mazumdar-Shaw, chairman and managing director of Indian biopharmaceutical company Biocon Ltd., will receive the 2014 Othmer Gold Medal at the Chemical Heritage Foundation’s 13th annual Heritage Day celebration May 15. CHF president and CEO Carsten Reinhardt said in a statement that Mazumdar

2.16 PM Jan 31st 2014

Web Messenger

Platinum Member

293815 Followers

Biocon  

Source:Economic Times - MUMBAI: Biocon has justified the Rs 19,500-57,500 pricing for its new breast cancer drug Canmab , with the company`s chairman and managing director Kiran Mazumdar-Shaw saying that the first biosimilar version of Swiss drug maker Roche`s offering has expanded the market.

12.04 PM Jan 25th 2014

Firstpost

Platinum Member

1036 Followers

Economy  

Source:FirstPost - Even though several corporate India executives have recently joined the Aam Aadmi Party while others like Bicon`s Kiran Mazumdar shaw have praised the party for itsanti-corruption stand and, the party` s populist measures are worrying investors on Dalal Street.At the heart

1.15 PM Jan 6th 2014

Web Messenger

Platinum Member

293815 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

7.08 PM Jan 2nd 2014

Web Messenger

Platinum Member

293815 Followers

Biocon  

Source:The Hindu BusinessLine - Rakesh Bamzai, President-Marketing, Biocon Ltd, is leaving the company to take up leadership role elsewhere. He has been associated with Biocon for 19 years.Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, said that Rakesh has decided to take up

1.04 PM Jan 2nd 2014

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.